Similar articles

• Ductal carcinoma in situ of the breast.

  Burstein HJ, Polyak K, Wong JS, Lester SC, Kaelin CM. Burstein HJ, et al. N Engl J Med. 2004 Apr 1;350(14):1430-41. doi: 10.1056/NEJMra031301. N Engl J Med. 2004. PMID: 15070793 Review. No abstract available.
• Re: Trends in the treatment of ductal carcinoma in situ of the breast.

  Zorbas H, Luxford K, Evans A, Villanueva EV. Zorbas H, et al. J Natl Cancer Inst. 2004 Aug 18;96(16):1258; author reply 1259-60. doi: 10.1093/jnci/djh249. J Natl Cancer Inst. 2004. PMID: 15316063 No abstract available.
• Ductal carcinoma in situ (DCIS) of the breast--a therapeutic dilemma.

  van Dongen JA, Bartelink H, Fentiman IS, Peterse JL. van Dongen JA, et al. Eur J Surg Oncol. 1987 Apr;13(2):123-5. Eur J Surg Oncol. 1987. PMID: 3030824 Review.
• Management of screen detected ductal carcinoma in situ of the female breast.

  Carpenter R, Boulter PS, Cooke T, Gibbs NM. Carpenter R, et al. Br J Surg. 1989 Jun;76(6):564-7. doi: 10.1002/bjs.1800760612. Br J Surg. 1989. PMID: 2547496
• Breast-conserving treatment for ductal carcinoma in situ: Impact of boost and tamoxifen on local recurrences.

  Cutuli B, Wiezzane N, Palumbo I, Barbieri P, Guenzi M, Huscher A, Borghesi S, Delva C, Iannone T, Vianello E, Rosetto ME, Aristei C. Cutuli B, et al. Cancer Radiother. 2016 Jun;20(4):292-8. doi: 10.1016/j.canrad.2016.04.004. Epub 2016 Jun 22. Cancer Radiother. 2016. PMID: 27344537